Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

DocGo (DCGO) Research & Development (2021 - 2025)

DocGo (DCGO) has 5 years of Research & Development data on record, last reported at $3.2 million in Q3 2025.

  • For Q3 2025, Research & Development rose 1.51% year-over-year to $3.2 million; the TTM value through Sep 2025 reached $13.5 million, up 21.52%, while the annual FY2024 figure was $11.6 million, 6.73% up from the prior year.
  • Research & Development reached $3.2 million in Q3 2025 per DCGO's latest filing, up from $3.0 million in the prior quarter.
  • Across five years, Research & Development topped out at $3.7 million in Q4 2024 and bottomed at $556931.0 in Q2 2021.
  • Average Research & Development over 5 years is $2.2 million, with a median of $2.4 million recorded in 2024.
  • Peak YoY movement for Research & Development: soared 135.61% in 2023, then fell 7.98% in 2024.
  • A 5-year view of Research & Development shows it stood at $1.3 million in 2021, then increased by 28.54% to $1.7 million in 2022, then soared by 85.03% to $3.2 million in 2023, then increased by 15.7% to $3.7 million in 2024, then dropped by 13.35% to $3.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Research & Development were $3.2 million in Q3 2025, $3.0 million in Q2 2025, and $3.6 million in Q1 2025.